
About Saarum Sciences
Saarum Sciences is a Healthcare company based in Hyderabad (India) founded in 2012. Biotechnology services focused on drug discovery platforms and research collaborations. Its Indian entity Saarum Sciences Private Limited reported revenue of βΉ1.9 Lakh. Saarum Sciences offers products and services including OncoPrime and Biobanking Services. Its focus areas include Life Sciences, Research Services, Biobanking and Biotechnology.
Company details
Saarum Sciences is identified as a provider of phenotypic drug discovery platforms, where OncoPrime is utilized to accelerate research using primary cells from tumor tissues. Access to patient-derived samples is facilitated through biobanking services, and custom RD projects are offered for target validation in a multi-omics context. Partnerships are established with biotech and pharma clients to enhance drug development processes, emphasizing physiologically relevant disease models. The companys infrastructure supports collaborations in academia and industry for efficient drug repositioning efforts.
- Headquarters Hyderabad, India
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website saarum.co.in
- Social LinkedIn X Facebook
- Legal Name Saarum Sciences Pvt Ltd
- Date of Incorporation 12 Feb, 2011
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹1.9 Lakh
FY 2024 · -49% YoY
- Net Loss-₹13,649
FY 2024 · -7% margin
- EBITDA₹1.2 Lakh
FY 2024 · 62% margin
Associated legal entities of Saarum Sciences
Saarum Sciences operates through Saarum Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Saarum Sciences Private Limited CIN U24232TG2011PTC072564 | Active | 12 Feb 2011 | Hyderabad, Telangana | ₹0.0 Cr | 2 | View details |
Products & Services of Saarum Sciences
Saarum Sciences offers a comprehensive portfolio of products and services, including OncoPrime and Biobanking Services.
A phenotypic drug discovery platform is utilized for characterizing disease phenotypes and studying drug responses in native states.
Access to patient-derived samples is provided through biobanking services to support research in biotechnology and pharma.
Board of directors of Saarum Sciences Private Limited (Saarum Sciences)
Saarum Sciences Private Limited is the primary company behind Saarum Sciences. The board of Saarum Sciences Private Limited currently have 2 directors; the longest-serving is Sreevatsa Natarajan Gopinath, appointed in 2011. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sreevatsa Natarajan Gopinath DIN 03250178 | Director | 12 Feb 2011 | 15 yrs 9 mo | Saarum Sciences Private Limited |
| Jugnu Jain DIN 03518645 | Director | 11 Oct 2012 | 14 yrs 1 mo | Saarum Sciences Private Limited |
Financials of Saarum Sciences
Figures of Saarum Sciences Private Limited, the primary company behind Saarum Sciences, for FY 2024. Revenue was ₹1.9 Lakh (-49% year on year). Net loss was -₹13,649 (-7% margin). EBITDA was ₹1.2 Lakh (62% margin). Revenue has grown at a compounded annual rate of -61% over three years and -44% over five years.
- ₹1.9 LakhRevenue · FY 2024 · -49% YoY
- -₹13,649Net loss · -7% margin
- ₹1.2 LakhEBITDA · 62% margin
- ₹1 LakhPaid-up capital
- -61%Revenue CAGR, 3 years
- -44%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Saarum Sciences Private Limited are on its company page.
Detailed financial statements for Saarum Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Saarum Sciences
Saarum Sciences was founded in 2012.
Saarum Sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Saarum Sciences, Saarum Sciences Private Limited, reported revenue of βΉ1.9 Lakh for FY 2024, down 49% year on year.
Saarum Sciences is identified as a provider of phenotypic drug discovery platforms, where OncoPrime is utilized to accelerate research using primary cells from tumor tissues. Access to patient-derived samples is facilitated through biobanking services, and custom RD projects are offered for target validation in a multi-omics context. Partnerships are established with biotech and pharma clients to enhance drug development processes, emphasizing physiologically relevant disease models. The companys infrastructure supports collaborations in academia and industry for efficient drug repositioning efforts.
Saarum Sciences offers OncoPrime and Biobanking Services.
Saarum Sciences operates through Saarum Sciences Private Limited.
The legal entities of Saarum Sciences currently have 2 directors, including Sreevatsa Natarajan Gopinath, Jugnu Jain.